#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Skin angiosarcoma Astrocytoma malignant Acute graft versus host disease in skin Ventricular fibrillation Raynaud's phenomenon Paraneoplastic neurological syndrome Bronchiectasis Kidney transplant rejection Congenital hypotransferrinaemia Thyroid cancer metastatic Immune-mediated enterocolitis Cognitive disorder CDKL5 deficiency disorder Hepato-lenticular degeneration Colon cancer More trials…

Learn about Rare Diseases

Acquired haemophilia – Diagnostics Angiosarcoma recurrent – Basic Information Mucopolysaccharidosis – Trials in Disease X-linked lymphoproliferative syndrome – Diagnostics Mucopolysaccharidosis II – Treatment Acquired haemophilia – Basic Information Mitochondrial myopathy – Life with Disease Isodicentric chromosome 15 syndrome – Treatment Prolymphocytic leukaemia – Treatment Alport’s syndrome – Trials in Disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

HUPERZINE A Io103 Acetate OMTX705 Treosulfan Cocarboxylase Tetrahydrate ACETYLCARNITINE HYDROCHLORIDE Cabergoline Niraparib Tosilate Monohydrate Crizotinib Imidapril Hydrochloride CLESROVIMAB MOLNUPIRAVIR Gallium (68Ga) Psma-R2 Ribitol Calcium Tramadol Hydrochloride CHONDROITIN SULFATE SODIUM YL201 HYDROGEN PEROXIDE Nofazinlimab More therapies…

Learn about Your Condition

Breast cancer stage III Demyelination Piriformis syndrome Food allergy Lichen sclerosus Angina pectoris Familial mediterranean fever Sciatica Breast cancer metastatic Bladder cancer stage III Dent's disease Endocrine disorder Porphyria non-acute Small intestine leiomyosarcoma Laryngeal cancer stage II More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe

🇦🇹 Austria

🇭🇷 Croatia

🇨🇿 Czech Republic

🇩🇰 Denmark

🇪🇪 Estonia

🇫🇮 Finland

🇫🇷 France

🇩🇪 Germany

🇮🇸 Iceland

🇮🇹 Italy

🇱🇻 Latvia

🇱🇹 Lithuania

🇳🇱 Netherlands

🇳🇴 Norway

🇵🇱 Poland

🇵🇹 Portugal

🇷🇴 Romania

🇸🇰 Slovakia

🇸🇮 Slovenia

🇪🇸 Spain

🇸🇪 Sweden

Glomerulonephritis membranous

Study of Felzartamab for Patients with Membranous Nephropathy Resistant to Anti-CD20 Therapy

Not recruiting

2 1 1 1
Investigated Drugs:
Study of Zanubrutinib and Tacrolimus for Patients with Primary Membranous Nephropathy

Not recruiting

4 1 1 1
Investigated Diseases:
- Glomerulonephritis membranous
Investigated Drugs:
- Zanubrutinib
- Tacrolimus
Study of Peginterferon Alfa-2a for Patients with Extramembranous Glomerulonephritis

Not recruiting

2 1 1 1
Investigated Diseases:
- Glomerulonephritis membranous
Investigated Drugs:
- Peginterferon Alfa-2A
Study of Obinutuzumab for Patients with Primary Membranous Nephropathy Resistant or Intolerant to Rituximab

Not recruiting

2 1 1 1
Investigated Diseases:
- Glomerulonephritis membranous
Investigated Drugs:

1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Glomerulonephritis membranous

Study of Felzartamab for Patients with Membranous Nephropathy Resistant to Anti-CD20 Therapy

Study of Zanubrutinib and Tacrolimus for Patients with Primary Membranous Nephropathy

Study of Peginterferon Alfa-2a for Patients with Extramembranous Glomerulonephritis

Study of Obinutuzumab for Patients with Primary Membranous Nephropathy Resistant or Intolerant to Rituximab

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies